TABLE 1.
Parameters | DKK1+/CKAP4+ (n = 55) | DKK1−/CKAP4− (n = 159) | p value | DKK1+/CKAP4− (n = 162) | p value | DKK1−/CKAP4+ (n = 36) | p value |
---|---|---|---|---|---|---|---|
General background | |||||||
Age (years) | 68 (41–80) | 69 (34–88) | 0.267 | 69 (33–87) | 0.545 | 71 (50–80) | 0.329 |
Sex (male/female) | 47/8 | 134/25 | 0.834 | 138/24 | 0.961 | 32/4 | 0.636 |
Hepatitis virus infection (non‐B non‐C/HB, HC) | 22/33 | 66/93 | 0.844 | 57/105 | 0.523 | 15/21 | 0.874 |
Child–Pugh class (A/B) | 50/5 | 158/1 | 0.001 | 156/6 | 0.116 | 34/2 | 0.536 |
Tumor factor | |||||||
Tumor number (>2/1) | 26/29 | 53/106 | 0.067 | 43/119 | 0.005 | 12/24 | 0.185 |
Tumor size (≥5 cm/<5 cm) | 30/25 | 65/94 | 0.079 | 63/99 | 0.043 | 18/18 | 0.671 |
Histology (poor/well or moderate) | 13/42 | 20/139 | 0.059 | 20/142 | 0.053 | 8/28 | 0.875 |
Lymph node metastasis (positive/negative) | 2/53 | 1/158 | 0.102 | 1/161 | 0.098 | 0/36 | 0.247 |
Vascular invasion (positive/negative) | 32/23 | 56/103 | 0.003 | 54/108 | 0.001 | 13/23 | 0.039 |
Capsular formation (positive/negative) | 45/10 | 137/21 | 0.385 | 138/23 | 0.495 | 31/5 | 0.589 |
Capsular invasion (positive/negative) | 38/17 | 112/46 | 0.802 | 110/48 | 0.942 | 24/12 | 0.809 |
UICC stage (IIIA–IVA/ IA–II) | 26/29 | 40/119 | 0.003 | 35/127 | 0.0004 | 12/24 | 0.185 |
Intrahepatic recurrence (positive/negative) | 33/22 | 83/76 | 0.316 | 89/73 | 0.512 | 16/20 | 0.145 |
Extrahepatic recurrence (positive/negative) | 14/41 | 14/145 | 0.003 | 12/150 | 0.001 | 6/30 | 0.316 |
Lymph node metastasis | 2 | 2 | 0.294 | 3 | 0.446 | 2 | 0.662 |
Lung metastasis | 9 | 8 | 0.012 | 3 | <0.0001 | 3 | 0.268 |
Bone metastasis | 4 | 4 | 0.133 | 6 | 0.275 | 1 | 0.358 |
Note: Continuous variables are expressed as medians with ranges. p values were calculated by comparing between double positive cases and each other cases. p values ≤0.05 are statistically significant.
Abbreviations: HB, hepatitis B; HC, hepatitis C; non‐B non‐C, non‐hepatitis B and non‐hepatitis C.